LEXICON PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Swain Judith L | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| Sullivan Diane E. | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| SOBECKI CHRISTOPHER J | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| BARKER SAM L | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| Amouyal Philippe | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| DEBBANE RAYMOND | — | Option Exercise | 36,810 | — | — | May 13, 2025 |
| Alexander Kristen | VP, Finance and Accounting | Tax Withholding | 17,862 | $0.67 | $11,968 | Feb 28, 2025 |
| McDermott Wendy | SVP, Human Resources | Option Exercise | 52,317 | — | — | Feb 28, 2025 |
| MAIN ALAN J | EVP, Innov & Chem Sciences | Option Exercise | 25,667 | — | — | Feb 28, 2025 |
| Granowitz Craig B | SVP, Chief Medical Officer | Option Exercise | 27,917 | — | — | Feb 28, 2025 |
| DeFrancesco Lisa | SVP, IR and Corp Comm | Option Exercise | 24,673 | — | — | Feb 28, 2025 |
| Crum Brian T | SVP, General Counsel & Secr. | Tax Withholding | 45,622 | $0.67 | $30,567 | Feb 28, 2025 |
| Artal Group S.A. | — | Option Exercise | 57,546,100 | — | — | May 10, 2024 |
| Swain Judith L | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| SOBECKI CHRISTOPHER J | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| LEFKOWITZ ROBERT J MD | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| DEBBANE RAYMOND | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| BARKER SAM L | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| Amouyal Philippe | — | Option Exercise | 8,032 | — | — | Apr 28, 2024 |
| Stichting Administratiekantoor Westend | — | Award / Grant | 1,150,922 | $108.50 | $124,875,037 | Mar 13, 2024 |
| Alexander Kristen | VP, Finance and Accounting | Option Exercise | 15,927 | — | — | Feb 28, 2024 |
| WADE JEFFREY L | President and CFO | Option Exercise | 49,113 | — | — | Feb 28, 2024 |
| McDermott Wendy | VP, Human Resources | Option Exercise | 18,944 | — | — | Feb 28, 2024 |
| MAIN ALAN J | EVP, Innov & Chem Sciences | Option Exercise | 25,666 | — | — | Feb 28, 2024 |
| Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Tax Withholding | 24,353 | $2.62 | $63,805 | Feb 28, 2024 |
| Granowitz Craig B | SVP, Chief Medical Officer | Option Exercise | 35,790 | — | — | Feb 28, 2024 |
| Crum Brian T | SVP, General Counsel & Secr. | Option Exercise | 8,750 | — | — | Feb 28, 2024 |
| COATS LONNEL | Chief Executive Officer | Option Exercise | 33,333 | — | — | Feb 28, 2024 |
| COATS LONNEL | Chief Executive Officer | Purchase | 90,000 | $1.05 | $94,500 | Nov 16, 2023 |
| Amouyal Philippe | — | Purchase | 200,000 | $1.01 | $202,000 | Nov 13, 2023 |
| COATS LONNEL | Chief Executive Officer | Purchase | 10,000 | $1.01 | $10,100 | Nov 10, 2023 |
| DEBBANE RAYMOND | — | Purchase | 342,874 | $1.08 | $370,304 | Oct 12, 2023 |
| WADE JEFFREY L | President and CFO | Purchase | 10,000 | $1.38 | $13,800 | Sep 14, 2023 |
| McDermott Wendy | VP, Human Resources | Purchase | 6,000 | $1.84 | $11,040 | Aug 4, 2023 |
| COATS LONNEL | Chief Executive Officer | Purchase | 10,000 | $2.16 | $21,600 | Jun 29, 2023 |
| McDermott Wendy | VP, Human Resources | Purchase | 10,000 | $2.43 | $24,300 | Jun 23, 2023 |
| COATS LONNEL | Chief Executive Officer | Purchase | 10,000 | $2.18 | $21,800 | Jun 23, 2023 |
| COATS LONNEL | Chief Executive Officer | Purchase | 40,000 | $2.31 | $92,400 | Jun 22, 2023 |
| WADE JEFFREY L | President and CFO | Purchase | 10,000 | $2.34 | $23,400 | Jun 20, 2023 |
| Artal Group S.A. | — | Purchase | 27,775,050 | $2.60 | $72,215,130 | Jun 5, 2023 |
| Swain Judith L | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| SOBECKI CHRISTOPHER J | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| Palantoni Frank | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| NIES ALAN S | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| LEFKOWITZ ROBERT J MD | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| DEBBANE RAYMOND | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| BARKER SAM L | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| Amouyal Philippe | — | Option Exercise | 9,302 | — | — | May 21, 2023 |
| Alexander Kristen | VP, Finance and Accounting | Option Exercise | 10,617 | — | — | Feb 28, 2023 |
| Seth Kiernan | VP, Chief Commercial Officer | Option Exercise | 14,833 | — | — | Feb 28, 2023 |